miR-125b is a protectomiR: A rising star for acute cardioprotection

dc.contributor.author	Varga, Zoltán
dc.contributor.author	Ágg, Bence
dc.contributor.author	Ferdinandy, Péter
dc.date.accessioned	2022-12-02T08:54:59Z
dc.date.available	2022-12-02T08:54:59Z
dc.date.issued	2018
dc.identifier	85040323833
dc.identifier.citation	journalVolume=115;journalTitle=JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY;pagerange=51-53;journalAbbreviatedTitle=J MOL CELL CARDIOL;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/8074
dc.identifier.uri	doi:10.1016/j.yjmcc.2017.12.010
dc.description.abstract	Myocardial infarction and resulting heart failure remain the leading causes of death worldwide. Therefore, novel therapies are required to protect the heart against the detrimental effects of acute ischemia/reperfusion injury. Micro-RNAs are promising novel targets for cardioprotection as highlighted by recent seminal position papers and reviews (Hausenloy et al., 2017; Varga et al., 2015; Perrino et al., 2017 [1-3]).
dc.format.extent	51-53
dc.relation.ispartof	urn:issn:0022-2828
dc.title	miR-125b is a protectomiR: A rising star for acute cardioprotection
dc.type	Journal Article
dc.date.updated	2019-12-05T10:42:12Z
dc.language.rfc3066	en
dc.rights.holder	NULL
dc.identifier.mtmt	3310978
dc.identifier.wos	000426620800006
dc.identifier.pubmed	29294330
dc.contributor.department	SE/AOK/I/Farmakológiai és Farmakoterápiás Intézet
dc.contributor.department	SE/AOK/K/Városmajori Szív- és Érgyógyászati Klinika
dc.contributor.institution	Semmelweis Egyetem